SE430158B - Forfarande for framstellning av tienyl-prostaglandiner - Google Patents

Forfarande for framstellning av tienyl-prostaglandiner

Info

Publication number
SE430158B
SE430158B SE7606318A SE7606318A SE430158B SE 430158 B SE430158 B SE 430158B SE 7606318 A SE7606318 A SE 7606318A SE 7606318 A SE7606318 A SE 7606318A SE 430158 B SE430158 B SE 430158B
Authority
SE
Sweden
Prior art keywords
tienyl
prostaglandines
procedure
preparation
tienyl prostaglandines
Prior art date
Application number
SE7606318A
Other languages
English (en)
Other versions
SE7606318L (sv
Inventor
W Bartmann
G Beck
D-B Reuschling
K Seeger
H Teufel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7606318L publication Critical patent/SE7606318L/sv
Publication of SE430158B publication Critical patent/SE430158B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J7/00—Adhesives in the form of films or foils
    • C09J7/10—Adhesives in the form of films or foils without carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7606318A 1975-06-05 1976-06-03 Forfarande for framstellning av tienyl-prostaglandiner SE430158B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2524955A DE2524955C3 (de) 1975-06-05 1975-06-05 Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
SE7606318L SE7606318L (sv) 1976-12-06
SE430158B true SE430158B (sv) 1983-10-24

Family

ID=5948288

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7606318A SE430158B (sv) 1975-06-05 1976-06-03 Forfarande for framstellning av tienyl-prostaglandiner
SE7910057A SE445112B (sv) 1975-06-05 1979-12-06 2-oxa-3-oxo-bicyklo/3,3,0/oktan-derivat till anvendning som mellanprodukter vid framstellning av tienyl-prostaglandiner

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7910057A SE445112B (sv) 1975-06-05 1979-12-06 2-oxa-3-oxo-bicyklo/3,3,0/oktan-derivat till anvendning som mellanprodukter vid framstellning av tienyl-prostaglandiner

Country Status (20)

Country Link
US (1) US4258053A (sv)
JP (3) JPS527954A (sv)
AT (1) AT360671B (sv)
AU (1) AU517489B2 (sv)
BE (1) BE842687A (sv)
CA (1) CA1086722A (sv)
CH (1) CH625213A5 (sv)
DE (1) DE2524955C3 (sv)
DK (1) DK152675C (sv)
ES (1) ES448387A1 (sv)
FR (1) FR2313036A1 (sv)
GB (1) GB1553914A (sv)
HU (1) HU175238B (sv)
IE (1) IE43849B1 (sv)
IL (1) IL49716A (sv)
IT (1) IT1061525B (sv)
LU (1) LU75076A1 (sv)
MX (1) MX3609E (sv)
NL (1) NL188693C (sv)
SE (2) SE430158B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04107991U (ja) * 1991-02-26 1992-09-17 テーダブリユ電気株式会社 ヘツドホン
WO2016153094A1 (ko) * 2015-03-26 2016-09-29 비스메르 주식회사 3-알콕시싸이오펜 유도체의 신규한 제조방법
CN106146455A (zh) * 2015-03-30 2016-11-23 维斯曼株式会社 3-烷氧基噻吩衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956284A (en) * 1972-07-13 1976-05-11 Pfizer Inc. Heterocyclic 15-substituted-ω-pentanorprostoglandins
GB1428137A (en) * 1972-09-27 1976-03-17 Ici Ltd Prostanoic acid derivatives
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3931279A (en) * 1973-05-21 1976-01-06 The Upjohn Company 5-Oxa prostaglandin F2.sub.α analogs
US3932289A (en) * 1973-11-09 1976-01-13 Chevron Research Company Preparation of overbased carbonated sulfurized magnesium alkylphenates
GB1484591A (en) * 1974-04-11 1977-09-01 Ono Pharmaceutical Co Prostaglandin compositions

Also Published As

Publication number Publication date
DK152675B (da) 1988-04-11
US4258053A (en) 1981-03-24
ATA413676A (de) 1980-06-15
AT360671B (de) 1981-01-26
DE2524955A1 (de) 1977-03-17
JPS527954A (en) 1977-01-21
NL7605856A (nl) 1976-12-07
IL49716A0 (en) 1976-08-31
JPS6261592B2 (sv) 1987-12-22
AU1460176A (en) 1977-12-08
CA1086722A (en) 1980-09-30
NL188693C (nl) 1992-09-01
JPS61243075A (ja) 1986-10-29
DE2524955C3 (de) 1981-12-03
JPS6210233B2 (sv) 1987-03-05
JPS6261593B2 (sv) 1987-12-22
DK152675C (da) 1988-10-31
IE43849B1 (en) 1981-06-17
HU175238B (hu) 1980-06-28
ES448387A1 (es) 1977-08-01
DK248176A (da) 1976-12-06
GB1553914A (en) 1979-10-10
AU517489B2 (en) 1981-08-06
FR2313036A1 (fr) 1976-12-31
IT1061525B (it) 1983-04-30
CH625213A5 (sv) 1981-09-15
SE7910057L (sv) 1979-12-06
BE842687A (fr) 1976-12-08
FR2313036B1 (sv) 1979-06-29
DE2524955B2 (de) 1981-02-12
SE7606318L (sv) 1976-12-06
IE43849L (en) 1976-12-05
JPS61246181A (ja) 1986-11-01
LU75076A1 (sv) 1977-03-07
MX3609E (es) 1981-03-31
SE445112B (sv) 1986-06-02
IL49716A (en) 1980-10-26

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
NO144209C (no) Fremgangsmaate for fremstilling av dialkylkarbonater
RO72997A (ro) Procedeu pentru prepararea benzoilureido-nitro-difenileteri
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE7513085L (sv) Forfarande for framstellning av etrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
AR217629A1 (es) Procedimiento de preparacion de derivados de tienotetrahidropiridina
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
AR211273A1 (es) Procendimiento de preparacion de nuevas (fenoxi-4-fenil)1-piperazinas
NO139555C (no) Fremgangsmaate for fremstilling av fosgen
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE7607717L (sv) Analogiforfarande for framstellning av l-pyroglutamyl-l-prolinamid
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE7600910L (sv) Forfarande for framstellning av polyuretaner
NO146141C (no) Fremgangsmaate til fremstilling av aminocyklitolantibiotika
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE430158B (sv) Forfarande for framstellning av tienyl-prostaglandiner
SE7605427L (sv) Forfarande for framstellning av klorcyan

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7606318-9

Format of ref document f/p: F